INDIA IPO
  • Home
  • About
    • About us
    • Our CSR
  • Services

    IPO

    • Initial Public Offering (IPO)
    • SME IPO Consultation
    • Mainline IPO Consultation
    • Follow-On Public Offer (FPO)
    • Pre-IPO Funding Consultants

    Capital Raising

    • Social Stock Exchange
    • Private Placement
    • Project Funding
    • REIT
    • SM REIT
    • Rights Issue Advisory
    • InvIT Rights Issue
    • InvIT Public Issue
    • InvIT Private Issue
    • Debt Syndication
    • Securitised Debt Instruments
    • Public Municipal Debt
    • Private Municipal Debt

    Finance Advisory

    • Business Valuation
    • Corporate Finance
    • Financial Modelling
    • Project Finance
  • Investors
  • Merchant Bankers

    SME

    • List of SME Merchant Bankers

    MAINBOARD

    • List of Mainboard Merchant Bankers
  • Resources

    Reports

    • Daily Reporter
    • IPO Calendar
    • Mainline IPO Report
    • SME IPO Report
    • SME IPOs by Sector
    • Mainboard IPOs by Sector

    IPO Knowledge

    • IPO World Magazine
    • IPO Process
    • Pre-IPO Process Guidance
    • IPO Blogs
    • Sector Wise IPO List In India
    • List of IPO Registrar

    Notifications / Circulars

    • BSE SME Eligibility Criteria
    • SEBI ICDR Amendment Regulations March 2025
    • SEBI SME IPO ICDR Amendments report Mar–Nov 2025
    • NSE Emerge Eligibility Criteria
    • ICDR
  • News/Updates
    • Markets & Money Update
    • IPO & Market Snaps
  • Contact Us
  • Check IPO Feasibility
Check IPO Feasibility
INDIA IPO
INDIA IPO

Contact Info:

  • +91-96506-37280
  • +011-47008280
  • info@indiaipo.in
  • 808, 8thFloor D-Mall, Netaji Subhash Place, Pitampura, Delhi-110034.
shape
  1. Home
  2. News
  3. Hindustan Laboratories receives SEBI observations for its proposed IPO
ipo services in India
India IPO
  • 30 Apr 2026
  • X
 Hindustan Laboratories receives SEBI observations for its proposed IPO

Hindustan Laboratories Limited has received SEBI observations for its proposed IPO of up to 1,41,00,000 equity shares. The funds will support working capital and corporate needs. The company primarily manufactures generic medicines for government institutions.

Hindustan Laboratories receives SEBI observations for its proposed IPO

A Ksheerasagar

Ksheera Sagar has been working as a Market Research Analyst at LiveMint for the past four years, covering stocks, commodities, and broader financial markets. In this role, he closely tracks daily market movements, corporate earnings, sector trends, and macroeconomic developments. He has over a decade of experience in the financial services industry and has previously worked with multiple organisations, including global investment bank J.P. Morgan, bringing strong research experience into the newsroom. During his career, he has gained extensive exposure to equity research, market analysis, and financial data interpretation, strengthening his expertise across asset classes and market cycles. He is known for his data-driven analysis and crisp, listicle-style market stories that break down complex financial developments across key markets for a wide audience. His strong research skills enable him to write detailed and insightful stories on stocks and sectors, focusing on the underlying factors driving market movements. His work combines quantitative insights with clear storytelling, presenting financial developments in a clear and structured manner. Moreover, he enjoys writing multibagger and listicle-style copies. Outside of work, Ksheera enjoys playing the piano and exploring new places. He has a keen interest in travel, music, and continuously learning about global markets and economic trends.

Recent News

Samvardhana Motherson International Incorporates Wholly Owned Digital Technology Subsidiary
Samvardhana Motherson International Incorporates Wholly Owne...
30 Apr 2026
Amic Forging Limited Schedules Board Meeting on May 11, 2026 for Fund Raising Proposals
Amic Forging Limited Schedules Board Meeting on May 11, 2026...
30 Apr 2026
Motherson Completes Acquisition of 51% Stake in Nissin Advanced Coating Indo Co.
Motherson Completes Acquisition of 51% Stake in Nissin Advan...
30 Apr 2026
Laurus Labs Q4 profit rises 19% to Rs 279 crore led by CDMO momentum
Laurus Labs Q4 profit rises 19% to Rs 279 crore led by CDMO...
30 Apr 2026
Iykot Hitech Toolroom Promoters Complete Divestment of 35.59% Stake to Aspect Global Ventures
Iykot Hitech Toolroom Promoters Complete Divestment of 35.59...
30 Apr 2026
Markets may struggle to hit 27,000; next few months seen choppy amid earnings concerns, says Rahul Arora
Markets may struggle to hit 27,000; next few months seen cho...
30 Apr 2026
From $61 billion to $900 billion in just 14 months - the insane story in tech: Anthropic could dethrone OpenAI as the most valuable startup
From $61 billion to $900 billion in just 14 months - the ins...
30 Apr 2026
Twamev Construction Issues Trading Ban to Promoter Group Member for Insider Trading Violation
Twamev Construction Issues Trading Ban to Promoter Group Mem...
30 Apr 2026
Angel One Allots 11.39 Lakh Equity Shares Under Employee Incentive Plan
Angel One Allots 11.39 Lakh Equity Shares Under Employee Inc...
30 Apr 2026
ACC Board Approves FY26 Results, Recommends ₹7.50 Dividend, Schedules AGM
ACC Board Approves FY26 Results, Recommends ₹7.50 Dividend,...
30 Apr 2026
pre ipo advisory services in India
  • GST No: 07AAHCB7068H2ZF

India IPO is a leading Indian business services platform that helps firms and companies to launch their initial public offerings (IPOs) in order to raise essential capital for growth and expansion while adding value & fueling the nation’s immense potential and future opportunities.

Follow us:

Facebook Twitter LinkedIn Instagram YouTube

Quick Links

  • Home
  • Blogs
  • Consultant
  • Youtube Videos
  • News
  • Contact Us
  • Career

Contact Information:

  • Corporate Office: 808, 8th Floor, D-Mall, Netaji Subhash Place, Pitampura, Delhi-110034
  • Regional Office: Office No. 601, Shagun Insignia, Ulwe, Sector-19, Navi Mumbai- 410206
  • Email: info@indiaipo.in
  • Mobile: +91-74283-37280, +91-96509-82781
  • Disclaimer  |
  • Privacy & Policy  |
  • Terms & Conditions  

Copyright © All rights reserved by - Bmarkt Tecamat Private Limited